e-ISSN: 2717-7157
  • Home
  • Aims and Scope
  • Editorial Board
  • Instructions for Authors
  • Table of Contents
  • Contact
  • Türkçe
Current Issue
Archive
Search
Online Subscription Login
Subscription Form
Most Popular
Download Articles Read Articles
Automated Perimetry
Carbonic Anhydrase Inhibitors
Intra Ocular Lens Power Calculation and Optic Biometry...
Visual Field Defects in Glaucoma
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Current Minimal Invasive Angle Procedures Without Implants for the Treatment of Glaucoma...
Intra Ocular Lens Power Calculation and Optic Biometry...
Automated Perimetry
Carbonic Anhydrase Inhibitors
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Glokom-Katarakt 2020 , Vol 15 , Num 2
Abstract Free Full Text Similar Articles Mail to Author
Outcomes of Transscleral Diode Laser Cyclophotocoagulation in End-Stage Glaucoma Patients
Ozer DURSUN1, Ayca YILMAZ2, Erdem DINC3, Gulhan TEMEL4
1Assistant Prof., MD., Mersin University Medical School, Ophthalmology Department, Mersin, Turkey
2Prof., MD., Mersin University Medical School, Ophthalmology Department, Mersin, Turkey
3Associate Prof., MD., Mersin University Medical School, Ophthalmology Department, Mersin, Turkey
4Associate Prof., MD., Mersin University Medical School, Biostatistics and Medical Informatics Department, Mersin, Turkey
DOI : 10.37844/glauc.cat.2020.15.21 Purpose: The aim of the study was to determine outcomes of diode laser transscleral cyclophotocoagulation (DLTCPC) in end-stage glaucoma (ESG).

Materials and Methods: We retrospectively reviewed fi le recordings of 23 eyes of 23 patients with ESG (9 female, 14 male). Visual acuity, intraocular pressure (IOP) levels, number of medical agents needed (MAN), pain sensation (PS) score and complications were evaluated before and after the procedure. Measurements obtained before and on week 1and at months 1, 3 and 6 after the procedure were analyzed statistically.

Results: There was a statistically signifi cant decrease in IOP values at all time points when compared to preoperative values. While the mean MAN was 3.91 before the laser treatment, it was 3.22 (p=0.004) at the fi nal control visit. PS was decreased from 2.67 before laser treatment to 0.89 (p=0.004) at fi nal control visit. There was no complication related to DLTCPC, including hypotonia.

Conclusion: In the treatment of ESG; DLTCPC treatment, which provides a signifi cant decrease in IOP, can decrease MAN, reduce pain complaints and has low complication rates, is an effective and reliable treatment method. Keywords : End-stage glaucoma, Diode laser transscleral cyclophotocoagulation, Intraocular pressure

Home
Aims and Scope
Editorial Board
Instructions for Authors
Table of Contents
Contact